SCHEMBL5742423

SCHEMBL5742423

CC(C)CNC(=O)Oc1ccc2c(=O)c3c(sc2c1)CC(C)(C)CC3

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.35
HSD17B10 Q99714 1/20 0.35
CACNA1G O43497 3/20 0.35
CACNA1H O95180 3/20 0.35
CACNA1I Q9P0X4 3/20 0.35
KIF11 P52732 1/20 0.34
PDE4B Q07343 1/20 0.34
PDE4D Q08499 1/20 0.34
SLC34A2 O95436 2/20 0.34
FAAH O00519 1/20 0.33
ACACB O00763 1/20 0.33
ACACA Q13085 1/20 0.33
BCHE P06276 2/20 0.32
ACHE P22303 2/20 0.32
FABP4 P15090 2/20 0.32
FABP5 Q01469 2/20 0.32
F9 P00740 1/20 0.32
F10 P00742 1/20 0.32
PLAU P00749 1/20 0.32
SMN1; SMN2 Q16637 2/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6656583 0.88 ACHE (0.35) SLC34A2FAAHBCHEACHEALDH1A1
SCHEMBL5741841 0.84 FABP4 (0.33) KIF11PDE4BPDE4DSLC34A2FABP4
SCHEMBL6510139 0.83 KMT2A (0.41) LMNAHSD17B10CACNA1GCACNA1HCACNA1I
SCHEMBL5740952 0.81 KIF11 (0.41) LMNAHSD17B10CACNA1GCACNA1HCACNA1I
SCHEMBL5741790 0.77 KIF11 (0.31) KIF11
SCHEMBL5739761 0.75 ACHE (0.37) LMNAHSD17B10KIF11SLC34A2ACHE
SCHEMBL5741839 0.74 RXRA (0.37) KIF11PDE4BPDE4DSLC34A2FABP4
SCHEMBL5740408 0.74 SLC34A2 (0.35) CACNA1GCACNA1HCACNA1IKIF11PDE4B
SCHEMBL5740285 0.73 CYP26A1 (0.40) HSD17B10CACNA1GCACNA1HCACNA1IKIF11
SCHEMBL6508440 0.73 KIF11 (0.34) KIF11PDE4BPDE4DSLC34A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1406891-B1 THIOCHROMENONES USED TO COMBAT PAINFUL CONDITIONS AND NEURODEGENERATIVE DISEASES BAYER HEALTHCARE AG (DE) 2006-03-22 EP disclosed